About this episode

This episode features discussions on the management of EGFR-Mutated Non-Small Cell Lung Cancer with insights from Dr Goldman and Dr Piotrowska.

Featuring perspectives from Dr Jonathan Goldman and Dr Zofia Piotrowska, including the following topics: Introduction (0:00) Current Management of Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) — Dr Goldman (0:38) Nonmetastatic EGFR-Mutated NSCLC, Exon 20 Insertion Mutations and Novel Agents — Dr Piotrowska (33:20) CME information and select publications

More episodes of Lung Cancer Update

• HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review · July 14, 2026 · 28 min
• Nonmetastatic Non-Small Cell Lung Cancer — An Interview with Dr Jamie E Chaft · July 11, 2026 · 60 min
• For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress · July 8, 2026 · 1h 29m
• Targeted Therapies for Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit · June 30, 2026 · 50 min
• First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck · June 18, 2026 · 41 min

Explore listener stats, chart rankings, contacts and more on the Lung Cancer Update podcast page.